manilatimes20 小时
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
("BioRestorative”, "BRTX” or the "Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem ...
Benzinga.com8 小时
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function
BioRestorative Therapies Inc. BRTX revealed on Wednesday new preliminary 26 to 52 week blinded data from the first 10 ...
WFLX7 小时
Why this kind of dog is more prone to spinal issues
Aimee said spinal or disc conditions are common in French bulldogs. They are more prone to it due to their shorts legs and ...
manilatimes23 小时
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business ...
In a podium presentation scheduled for tomorrow morning, new preliminary 26-52 week blinded data from the ongoing Phase 2 ...
pharmaphorum20 小时
Boehringer bags first approval for rare skin disease drug
The approval comes on the back of the recently-published EFFISAYIL 1 trial, in which a single intravenous dose of spesolimab was compared to placebo in 53 people presenting with a GPP flare ...